Jeff Pavell

Jeff Pavell

Net worth: 7 410 $ as of 2026-05-30

59 year
Health Services
Health Technology
Consumer Services

Profile

Dr. Jeff Pavell is an Independent Director at Hoth Therapeutics, Inc., an Independent Director at Silo Pharma, Inc., an Independent Director at FoxWayne Enterprises Acquisition Corp., an Associate Director-Pain Medicine at Center For Advanced Surgery LLC and a Chief-Rehabilitation Medicine at Englewood Hospital & Medical Center, Inc. He is on the Board of Directors at Hoth Therapeutics, Inc., Silo Pharma, Inc. and FoxWayne Enterprises Acquisition Corp.
Dr. Pavell was previously employed as a Partner by Patient Care Associates, Inc. and a Partner by Physical Medicine & Rehabilitation Center PA. He received his undergraduate degree from John Hopkins University Atlantic Basin Policy Institute and a doctorate degree from New York College of Osteopathic Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-25 5,075 ( 0.03% ) 7 410 $ 2026-05-30

Jeff Pavell active positions

CompaniesPositionStart
FOXWAYNE ENTERPRISES ACQUISITION CORP. Director/Board Member 2020-12-31
SILO PHARMA, INC. Director/Board Member 2022-09-26
ROCKET ONE INC. Director/Board Member 2022-12-06
Corporate Officer/Principal 1999-12-31
Corporate Officer/Principal 2002-03-31

Former positions of Jeff Pavell

CompaniesPositionEnd
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Jeff Pavell's experience

Training of Jeff Pavell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

28

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Services

Consumer Services

Consumer Services

Health Services

Health Technology

Finance

Health Services

Health Services